BLUEWAVE Technologies is a healthtech startup and the creator of the BLUEWAVE, a device that can deodorize items with its proprietary ozone infusion technology in as little as 5 minutes, without using any water, detergents, or added chemicals. The device is completely closed loop and filters out all of the excess ozone at the end of the cycle, making it safe to use anywhere.
It has achieved kills against MRSA and Pseudomonas aeruginosa in independent lab tests – not only on hard surfaces, but also through porous materials – and the company is currently working to complete their antibacterial efficacy claims.
The co-founders, Kenneth Cherisol, Miles Clark and Justin Zhou previously worked together at a high-tech battery startup and have been working together for over 10 years.
BLUEWAVE Technologies is headquartered in New York City, and has its own manufacturing facility near Orlando. They are a portfolio company of Morgan Stanley and Jacksonville’s PS27 Ventures.
They are currently in Orthotic & Prosthetic clinics and are now expanding to orthopedics, physical therapy and sports medicine. The BLUEWAVE device can quickly deodorize items in these markets that other solutions cannot treat, leaving both clinicians and patients ecstatic with the results.
“Since using BLUEWAVE, we’ve been able to make even some of the more odorous patients items look and feel like they are brand new. Also by making things smell better patients are not self-conscious and they are more inclined to improve their compliance and not feel like they dislike the orthosis because it smells.
Prosthetic patients always comment about the smell of liners or their prosthesis so it’s great to be able to freshen everything and make them feel better and less self-conscious,” said Brittany Stresing, Owner of Limbonics. BLUEWAVE Technologies’ goal is to revolutionize the way clinicians can treat orthotic and prosthetic devices to increase the quality of the work environment and patient satisfaction.
